This is a regulatory disclosure intimation submitted to BSE Limited regarding an upcoming board meeting of Sharma East India Hospitals & Medical Research Limited.
The Board of Directors meeting is scheduled to be held on Saturday, November 7, 2026, at the company's registered office located at Jaipur Hospital, Near SMS Stadium, Lal Kothi, Tonk Road, Jaipur-302015, Rajasthan.
The primary agenda items for the board meeting include:
- Approval of IND-AS compliant Standalone Un-audited Financial Results along with Limited Review Report for the quarter and half year ended on 30th September 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
- Any other business with permission of the Chair and with consent of a majority of Directors present, including at least one Independent Director
The company has confirmed that the Trading Window for dealing in securities of the Company is closed from Thursday, 1st October 2026 until Forty-Eight (48) hours after declaration of the un-audited financial results for the quarter and half year ended on 30th September 2026. This closure is in accordance with the Company's Code of Conduct for Prevention of Insider Trading and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The intimation was signed by Bhawaria Sharma, Company Secretary and Compliance Officer (Membership No. A61665), from Jaipur on November 3, 2026.